| GO ID | GO:0001525 |
| Ontology | BP |
| GO Term | angiogenesis |
| Definition | Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
|
MEIS1 |
Meis homeobox 1 |
4211 |
O00470 |
chr2: 66,433,452-66,573,869 |
|
KRIT1 |
KRIT1, ankyrin repeat containing |
889 |
O00522 |
chr7: 92,198,969-92,246,166 |
|
NRP1 |
neuropilin 1 |
8829 |
O14786 |
chr10: 33,177,492-33,336,262 |
|
EREG |
epiregulin |
2069 |
O14944 |
chr4: 74,365,143-74,388,751 |
|
ANGPT2 |
angiopoietin 2 |
285 |
O15123 |
chr8: 6,499,651-6,563,409 |
|
HOXA3 |
homeobox A3 |
3200 |
O43365 |
chr7: 27,106,184-27,152,581 |
|
TBX1 |
T-box 1 |
6899 |
O43435 |
chr22: 19,756,703-19,783,593 |
|
HS6ST1 |
heparan sulfate 6-O-sulfotransferase 1 |
9394 |
O60243 |
chr2: 128,236,716-128,318,577 |
|
NRP2 |
neuropilin 2 |
8828 |
O60462 |
chr2: 205,681,990-205,798,133 |
|
SRPX2 |
sushi-repeat containing protein, X-linked 2 |
27286 |
O60687 |
chrX: 100,644,166-100,675,788 |
|
RAMP1 |
receptor (G protein-coupled) activity modifying protein 1 |
10267 |
O60894 |
chr2: 237,858,893-237,912,114 |
|
PDCD6 |
programmed cell death 6 |
10016 |
O75340 |
chr5: 271,621-353,856 |
|
FGF18 |
fibroblast growth factor 18 |
8817 |
O76093 |
chr5: 171,419,656-171,457,623 |
|
TSPAN12 |
tetraspanin 12 |
23554 |
O95859 |
chr7: 120,787,320-120,858,402 |
|
FN1 |
fibronectin 1 |
2335 |
P02751 |
chr2: 215,360,440-215,436,172 |
|
ANG |
angiogenin, ribonuclease, RNase A family, 5 |
283 |
P03950 |
chr14: 20,684,177-20,698,971 |
|
PDGFA |
platelet-derived growth factor alpha polypeptide |
5154 |
P04085 |
chr7: 497,258-520,296 |
|
APOD |
apolipoprotein D |
347 |
P05090 |
chr3: 195,568,702-195,584,205 |
|
SERPINE1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
5054 |
P05121 |
chr7: 101,127,089-101,139,266 |
|
JUN |
jun proto-oncogene |
3725 |
P05412 |
chr1: 58,780,788-58,784,327 |
|
GPI |
glucose-6-phosphate isomerase |
2821 |
P06744 |
chr19: 34,359,480-34,402,156 |
|
ITGAV |
integrin subunit alpha V |
3685 |
P06756 |
chr2: 186,590,065-186,680,901 |
|
ANXA2 |
annexin A2 |
302 |
P07355 |
chr15: 60,347,134-60,402,883 |
|
MMP2 |
matrix metallopeptidase 2 |
4313 |
P08253 |
chr16: 55,389,700-55,506,691 |
|
COL4A2 |
collagen, type IV, alpha 2 |
1284 |
P08572 |
chr13: 110,305,812-110,513,027 |
|
ITGA5 |
integrin subunit alpha 5 |
3678 |
P08648 |
chr12: 54,395,261-54,419,460 |
|
HMOX1 |
heme oxygenase 1 |
3162 |
P09601 |
chr22: 35,380,361-35,394,214 |
|
CXCL8 |
chemokine (C-X-C motif) ligand 8 |
3576 |
P10145 |
chr4: 73,740,506-73,743,716 |
|
FGFR1 |
fibroblast growth factor receptor 1 |
2260 |
P11362 |
chr8: 38,411,138-38,468,834 |
|
CCL2 |
chemokine (C-C motif) ligand 2 |
6347 |
P13500 |
chr17: 34,255,218-34,257,203 |
|
SCG2 |
secretogranin II |
7857 |
P13521 |
chr2: 223,596,940-223,602,503 |
|
VEGFA |
vascular endothelial growth factor A |
7422 |
P15692 |
chr6: 43,770,184-43,786,487 |
|
PRKCA |
protein kinase C, alpha |
5578 |
P17252 |
chr17: 66,302,636-66,810,743 |
|
TAL1 |
T-cell acute lymphocytic leukemia 1 |
6886 |
P17542 |
chr1: 47,216,290-47,232,220 |
|
XBP1 |
X-box binding protein 1 |
7494 |
P17861 |
chr22: 28,794,555-28,800,597 |
|
TYMP |
thymidine phosphorylase |
1890 |
P19971 |
chr22: 50,525,752-50,530,056 |
|
EFNA1 |
ephrin-A1 |
1942 |
P20827 |
chr1: 155,127,460-155,134,857 |
|
S1PR1 |
sphingosine-1-phosphate receptor 1 |
1901 |
P21453 |
chr1: 101,236,888-101,241,518 |
|
SAT1 |
spermidine/spermine N1-acetyltransferase 1 |
6303 |
P21673 |
chrX: 23,783,173-23,786,226 |
|
FGFR2 |
fibroblast growth factor receptor 2 |
2263 |
P21802 |
chr10: 121,478,334-121,598,458 |
|
PTPRB |
protein tyrosine phosphatase, receptor type, B |
5787 |
P23467 |
chr12: 70,515,866-70,637,440 |
|
COL8A2 |
collagen, type VIII, alpha 2 |
1296 |
P25067 |
chr1: 36,095,236-36,125,220 |
|
CTGF |
connective tissue growth factor |
1490 |
P29279 |
chr6: 131,948,176-131,951,373 |
|
EPHB2 |
EPH receptor B2 |
2048 |
P29323 |
chr1: 22,710,839-22,921,500 |
|
NOS3 |
nitric oxide synthase 3 |
4846 |
P29474 |
chr7: 150,990,995-151,014,588 |
|
S100A7 |
S100 calcium binding protein A7 |
6278 |
P31151 |
chr1: 153,457,744-153,460,701 |
|
FGF9 |
fibroblast growth factor 9 |
2254 |
P31371 |
chr13: 21,671,383-21,704,498 |
|
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
5743 |
P35354 |
chr1: 186,671,791-186,680,427 |
|
RORA |
RAR-related orphan receptor A |
6095 |
P35398 |
chr15: 60,488,284-61,229,319 |
|
MYH9 |
myosin, heavy chain 9, non-muscle |
4627 |
P35579 |
chr22: 36,281,281-36,388,018 |
|
TIE1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
7075 |
P35590 |
chr1: 43,300,993-43,323,108 |
|
GJA5 |
gap junction protein alpha 5 |
2702 |
P36382 |
chr1: 147,756,199-147,773,362 |
|
COL15A1 |
collagen, type XV, alpha 1 |
1306 |
P39059 |
chr9: 98,943,179-99,070,792 |
|
COL18A1 |
collagen, type XVIII, alpha 1 |
80781 |
P39060 |
chr21: 45,405,137-45,513,720 |
|
ID1 |
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
3397 |
P41134 |
chr20: 31,605,283-31,606,515 |
|
LEP |
leptin |
3952 |
P41159 |
chr7: 128,241,284-128,257,628 |
|
ELK3 |
ELK3, ETS-domain protein (SRF accessory protein 2) |
2004 |
P41970 |
chr12: 96,194,382-96,269,835 |
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5290 |
P42336 |
chr3: 179,148,114-179,240,093 |
|
MCAM |
melanoma cell adhesion molecule |
4162 |
P43121 |
chr11: 119,308,529-119,321,521 |
|
SYK |
spleen tyrosine kinase |
6850 |
P43405 |
chr9: 90,801,787-90,898,549 |
|
LEPR |
leptin receptor |
3953 |
P48357 |
chr1: 65,420,652-65,641,559 |
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
5294 |
P48736 |
chr7: 106,865,278-106,907,145 |
|
PGF |
placental growth factor |
5228 |
P49763 |
chr14: 74,941,834-74,955,784 |
|
VEGFB |
vascular endothelial growth factor B |
7423 |
P49765 |
chr11: 64,234,538-64,238,793 |
|
VEGFC |
vascular endothelial growth factor C |
7424 |
P49767 |
chr4: 176,683,538-176,792,727 |
|
MMP14 |
matrix metallopeptidase 14 |
4323 |
P50281 |
chr14: 22,836,557-22,849,027 |
|
PLCD1 |
phospholipase C delta 1 |
5333 |
P51178 |
chr3: 38,007,496-38,029,762 |
|
PRKX |
protein kinase, X-linked |
5613 |
P51817 |
chrX: 3,604,370-3,713,608 |
|
EPHB4 |
EPH receptor B4 |
2050 |
P54760 |
chr7: 100,802,565-100,827,521 |
|
EPHB1 |
EPH receptor B1 |
2047 |
P54762 |
chr3: 134,597,801-135,260,467 |
|
PTEN |
phosphatase and tensin homolog |
5728 |
P60484 |
chr10: 87,863,113-87,971,930 |
|
TGFB2 |
transforming growth factor beta 2 |
7042 |
P61812 |
chr1: 218,346,235-218,444,619 |
|
RHOB |
ras homolog family member B |
388 |
P62745 |
chr2: 20,447,074-20,449,445 |
|
ADAM8 |
ADAM metallopeptidase domain 8 |
101 |
P78325 |
chr10: 133,262,403-133,276,868 |
|
SRPK2 |
SRSF protein kinase 2 |
6733 |
P78362 |
chr7: 105,110,704-105,399,308 |
|
JAG1 |
jagged 1 |
182 |
P78504 |
chr20: 10,637,684-10,674,107 |
|
HSPG2 |
heparan sulfate proteoglycan 2 |
3339 |
P98160 |
chr1: 21,822,245-21,937,297 |
|
TEK |
TEK tyrosine kinase, endothelial |
7010 |
Q02763 |
chr9: 27,109,141-27,230,175 |
|
CAV1 |
caveolin 1 |
857 |
Q03135 |
chr7: 116,524,785-116,561,184 |
|
TNFAIP2 |
TNF alpha induced protein 2 |
7127 |
Q03169 |
chr14: 103,123,442-103,137,439 |
|
PTK2 |
protein tyrosine kinase 2 |
5747 |
Q05397 |
chr8: 140,657,900-141,002,216 |
|
MFGE8 |
milk fat globule-EGF factor 8 protein |
4240 |
Q08431 |
chr15: 88,898,683-88,913,411 |
|
PDE3B |
phosphodiesterase 3B |
5140 |
Q13370 |
chr11: 14,643,723-14,872,044 |
|
IL18 |
interleukin 18 |
3606 |
Q14116 |
chr11: 112,143,251-112,164,117 |
|
VEZF1 |
vascular endothelial zinc finger 1 |
7716 |
Q14119 |
chr17: 57,971,547-57,988,259 |
|
PRKD1 |
protein kinase D1 |
5587 |
Q15139 |
chr14: 29,576,479-30,191,898 |
|
SHB |
Src homology 2 domain containing adaptor protein B |
6461 |
Q15464 |
chr9: 37,919,134-38,069,211 |
|
TGFBI |
transforming growth factor beta induced |
7045 |
Q15582 |
chr5: 136,028,895-136,063,818 |
|
MAPK14 |
mitogen-activated protein kinase 14 |
1432 |
Q16539 |
chr6: 36,027,677-36,111,236 |
|
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
3091 |
Q16665 |
chr14: 61,695,513-61,748,259 |
|
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
1545 |
Q16678 |
chr2: 38,066,973-38,109,902 |
|
CSPG4 |
chondroitin sulfate proteoglycan 4 |
1464 |
Q6UVK1 |
chr15: 75,674,322-75,712,848 |
|
ARHGAP22 |
Rho GTPase activating protein 22 |
58504 |
Q7Z5H3 |
chr10: 48,446,034-48,656,265 |
|
TMPRSS6 |
transmembrane protease, serine 6 |
164656 |
Q8IU80 |
chr22: 37,065,436-37,109,563 |
|
UNC5B |
unc-5 netrin receptor B |
219699 |
Q8IZJ1 |
chr10: 71,212,570-71,302,864 |
|
ARHGAP24 |
Rho GTPase activating protein 24 |
83478 |
Q8N264 |
chr4: 85,475,114-86,002,670 |
|
AGGF1 |
angiogenic factor with G-patch and FHA domains 1 |
55109 |
Q8N302 |
chr5: 77,029,251-77,065,234 |
|
NDNF |
neuron-derived neurotrophic factor |
79625 |
Q8TB73 |
chr4: 121,035,613-121,073,021 |
|
STAB2 |
stabilin 2 |
55576 |
Q8WWQ8 |
chr12: 103,587,273-103,766,727 |
|
NRCAM |
neuronal cell adhesion molecule |
4897 |
Q92823 |
chr7: 108,147,623-108,456,717 |
|
MYDGF |
myeloid-derived growth factor |
56005 |
Q969H8 |
chr19: 4,641,374-4,670,370 |
|
APOLD1 |
apolipoprotein L domain containing 1 |
81575 |
Q96LR9 |
chr12: 12,725,917-12,829,975 |
|
NOX5 |
NADPH oxidase, EF-hand calcium binding domain 5 |
79400 |
Q96PH1 |
chr15: 68,930,525-69,062,743 |
|
MMP19 |
matrix metallopeptidase 19 |
4327 |
Q99542 |
chr12: 55,835,433-55,842,966 |
|
EPAS1 |
endothelial PAS domain protein 1 |
2034 |
Q99814 |
chr2: 46,293,667-46,386,703 |
|
CIB1 |
calcium and integrin binding 1 |
10519 |
Q99828 |
chr15: 90,229,975-90,234,047 |
|
PDCD10 |
programmed cell death 10 |
11235 |
Q9BUL8 |
chr3: 167,683,298-167,734,939 |
|
HTATIP2 |
HIV-1 Tat interactive protein 2 |
10553 |
Q9BUP3 |
chr11: 20,363,685-20,383,783 |
|
JAM3 |
junctional adhesion molecule 3 |
83700 |
Q9BX67 |
chr11: 134,068,925-134,152,001 |
|
NAA15 |
N(alpha)-acetyltransferase 15, NatA auxiliary subunit |
80155 |
Q9BXJ9 |
chr4: 139,301,455-139,420,033 |
|
PRKD2 |
protein kinase D2 |
25865 |
Q9BZL6 |
chr19: 46,674,275-46,717,127 |
|
PDCL3 |
phosducin like 3 |
79031 |
Q9H2J4 |
chr2: 100,562,690-100,576,735 |
|
SEMA4A |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
64218 |
Q9H3S1 |
chr1: 156,147,366-156,177,752 |
|
FZD8 |
frizzled class receptor 8 |
8325 |
Q9H461 |
chr10: 35,638,249-35,642,278 |
|
SOX17 |
SRY-box 17 |
64321 |
Q9H6I2 |
chr8: 54,457,935-54,460,888 |
|
TNFRSF12A |
tumor necrosis factor receptor superfamily member 12A |
51330 |
Q9NP84 |
chr16: 3,018,445-3,022,383 |
|
ESM1 |
endothelial cell-specific molecule 1 |
11082 |
Q9NQ30 |
chr5: 54,977,864-55,022,671 |
|
DLL4 |
delta-like 4 (Drosophila) |
54567 |
Q9NR61 |
chr15: 40,929,340-40,939,072 |
|
ERAP1 |
endoplasmic reticulum aminopeptidase 1 |
51752 |
Q9NZ08 |
chr5: 96,760,810-96,808,100 |
|
VAV3 |
vav guanine nucleotide exchange factor 3 |
10451 |
Q9UKW4 |
chr1: 107,571,160-107,965,144 |
|
THSD7A |
thrombospondin type 1 domain containing 7A |
221981 |
Q9UPZ6 |
chr7: 11,370,357-11,832,198 |
|
HIF3A |
hypoxia inducible factor 3, alpha subunit |
64344 |
Q9Y2N7 |
chr19: 46,297,046-46,343,433 |
|
PLXND1 |
plexin D1 |
23129 |
Q9Y4D7 |
chr3: 129,555,175-129,606,818 |
|
HEY1 |
hes-related family bHLH transcription factor with YRPW motif 1 |
23462 |
Q9Y5J3 |
chr8: 79,764,010-79,767,863 |
|
ADGRG1 |
adhesion G protein-coupled receptor G1 |
9289 |
Q9Y653 |
chr16: 57,610,652-57,665,580 |
|
WASF2 |
WAS protein family member 2 |
10163 |
Q9Y6W5 |
chr1: 27,404,226-27,490,158 |